Physician profile
Morgan E Woods
NPI 1912062761
$3,201.05
in general payments reported to CMS, 2019-2025
14 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $307 · 2022: $470 · 2023: $858 · 2024: $563 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,403 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,403.20 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,529.57 | 2021-2025 | |
| Lilly USA, LLC | $739.98 | 2021-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $204.92 | 2024-2025 | Wegovy, Saxenda |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.90 | 2022-2025 | Jardiance |
| Abbott Laboratories | $138.64 | 2022-2024 | Freestyle Libre 3 |
| Indivior INC. | $107.27 | 2024 | Sublocade |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $75.66 | 2022-2024 | Caplyta |
| Pfizer INC. | $64.05 | 2023-2024 | |
| Amgen INC. | $58.24 | 2025 | Repatha |
| Hologic Sales and Service, LLC | $51.23 | 2021-2025 | Aptima |
| Alkermes, INC. | $25.35 | 2025 | Vivitrol |
| Almatica Pharma LLC | $21.62 | 2023 | Gralise |
| Hikma Pharmaceuticals USA | $21.00 | 2024 | Kloxxado |
| Currax Pharmaceuticals LLC | $16.62 | 2024 | Contrave, Onzetra Xsail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.